A Study of HNC042 in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics.

NCT03740555 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: HNC042 single dose
DRUG: Placebo single dose
DRUG: HNC042 multiple ascending doses
DRUG: Placebo multiple ascending doses

Sponsor

Guangzhou Henovcom Bioscience Co. Ltd.